Patent · US Active

Lignanamides and a method of treating neurodegenerative diseases by using the same

US10155721B2 · kind B2 · utility

1Cited by

0References

4Claims

0Family size

Assignee

Macau University of Science and Technology · CN

Inventors

Guo-Yuan Zhu · Macau, CN
Zhi-Hong Jiang · Taipa, CN
Ji Yang · Incheon, KR
Xiao Jun Yao · Taipa, CN
Xin Liu · Wuxi, CN
Jing Fu · Shanghai, CN
Li-Ping Bai · Taipa, CN
Liang Liu · Macau, CN

Key dates

Filing date	Apr 24, 2017
Grant date	Dec 18, 2018
Priority date	—
Expiry date	Apr 24, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2603/97
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

One example embodiment is a lignanamide that includes a benzo-angular triquinane skeleton. The lignanamide is represented by formula (I) and any derivative of the formula (I), in which R is represented by —OH or —OCH3. Another example embodiment relates to a method of treating neurodegenerative disease by administering the lignanamide of the formula (I) to a person in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.